methylprednisolone and Angiofollicular Lymph Hyperplasia

methylprednisolone has been researched along with Angiofollicular Lymph Hyperplasia in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (7.69)18.2507
2000's0 (0.00)29.6817
2010's10 (76.92)24.3611
2020's2 (15.38)2.80

Authors

AuthorsStudies
Bao, W; Cui, Z; Deng, Z; Guo, H; Pan, Y; Tian, X; Wang, S; Wang, Y; Zheng, D; Zhou, S1
Arakawa, A; Iizuka, M; Matsubara, E; Matsuda, S; Tanaka, H; Yamazaki, H; Yoshikawa, N; Yoshizawa, T1
Blumenschein, DI; Campos Neto, GC; de Souza Santos, FP; Hamerschlak, N; José, FF; Kerbauy, LN; Malheiros, DMAC; Pasqualin, DDC; Perini, GF; Piovesan, R1
Cui, Z; Gu, QH; Hu, SY; Jia, XY; Wang, SX; Zhao, MH; Zou, WZ1
Maruyama, S; Ozeki, T; Shigematsu, C; Tsuji, M; Yamamoto, J1
Eiro, M; Fujiwara, M; Iwasaki, T; Kanno, M; Kazama, JJ; Numata, T; Oda, A; Saito, H; Satoh, M; Tanaka, K; Tanaka, M1
DiSantis, F; Hames, N; Weiss, L1
Concellón, MA; Delgado-Beltrán, C; Fuertes, MA; Gracia-Cazaña, T1
Budzyński, A; Gałązka, K; Jagiełło, W; Milewski, M; Musiał, J1
Fujii, A; Fujiwara, H; Ishimoto, Y; Kotera, N; Kurita, N; Mise, N; Sugimoto, T; Tanaka, M; Tanaka, S; Yamaguchi, Y1
Kusano, E; Morishita, Y; Muto, S; Oh, I; Otani, N; Saito, O; Takemoto, F1
Ashkenazi, YJ; Ben-Chetrit, E; Bnaya, A; Somech, R; Vernea, F1
Funabiki, K; Kaneko, S; Kawano, Y; Terajima, M; Tomino, Y; Tomita, H1

Reviews

1 review(s) available for methylprednisolone and Angiofollicular Lymph Hyperplasia

ArticleYear
Idiopathic multicentric Castleman disease with Sjögren's syndrome and secondary membranous nephropathy: a case report and review of the literature.
    BMC nephrology, 2020, 12-04, Volume: 21, Issue:1

    Topics: Antibodies, Antinuclear; Antibodies, Monoclonal, Humanized; Castleman Disease; Cyclophosphamide; Diagnostic Errors; Female; Glomerulonephritis, Membranous; Glucocorticoids; Humans; Immunosuppressive Agents; Interleukin-6; Maintenance Chemotherapy; Methylprednisolone; Middle Aged; Remission Induction; Sjogren's Syndrome; Thymus Hyperplasia; Thymus Neoplasms

2020

Other Studies

12 other study(ies) available for methylprednisolone and Angiofollicular Lymph Hyperplasia

ArticleYear
Aseptic Meningitis-retention Syndrome Associated with Tocilizumab in a Patient with Idiopathic Multicentric Castleman Disease.
    Internal medicine (Tokyo, Japan), 2021, Dec-15, Volume: 60, Issue:24

    Topics: Antibodies, Monoclonal, Humanized; Castleman Disease; Humans; Male; Meningitis, Aseptic; Methylprednisolone; Middle Aged

2021
A life-threatening case of TAFRO syndrome with dramatic response to tocilizumab, rituximab, and pulse steroids: The first case report in Latin America.
    Medicine, 2017, Volume: 96, Issue:13

    Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Castleman Disease; Drug Therapy, Combination; Female; Humans; Immunologic Factors; Methylprednisolone; Middle Aged; Rituximab

2017
The Clinical and Immunologic Features of Patients With Combined Anti-GBM Disease and Castleman Disease.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2018, Volume: 71, Issue:6

    Topics: Adult; Anti-Glomerular Basement Membrane Disease; Autoantigens; Biopsy, Needle; Castleman Disease; Collagen Type IV; Combined Modality Therapy; Comorbidity; Epitopes; Follow-Up Studies; Hospitalization; Humans; Immunoglobulin G; Immunohistochemistry; Male; Methylprednisolone; Middle Aged; Plasma Exchange; Pulse Therapy, Drug; Rare Diseases; Sampling Studies; Severity of Illness Index; Treatment Outcome

2018
Thrombotic microangiopathy on kidney biopsy in a patient with TAFRO syndrome.
    CEN case reports, 2018, Volume: 7, Issue:2

    Topics: Castleman Disease; Edema; Female; Glomerular Mesangium; Glucocorticoids; Humans; Kidney; Kidney Diseases; Kidney Glomerulus; Methylprednisolone; Middle Aged; Sclerosis; Syndrome; Thrombotic Microangiopathies; Treatment Outcome

2018
Pathological findings of progressive renal involvement in a patient with TAFRO syndrome.
    CEN case reports, 2019, Volume: 8, Issue:4

    Topics: Abdominal Pain; Anti-Inflammatory Agents; Castleman Disease; Cyclosporine; Female; Fever; Glomerulonephritis, Membranoproliferative; Humans; Immunosuppressive Agents; Kidney; Kidney Glomerulus; Methylprednisolone; Middle Aged; Thrombocytopenia; Treatment Outcome; Vascular Endothelial Growth Factor A

2019
A Teenager With Painful Oral and Genital Lesions.
    Clinical pediatrics, 2019, Volume: 58, Issue:9

    Topics: Adolescent; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Castleman Disease; Diagnosis, Differential; Genital Diseases, Male; Humans; Immunoglobulins; Immunologic Factors; Male; Methylprednisolone; Mycophenolic Acid; Oral Ulcer; Pain; Retroperitoneal Space; Rituximab; Tomography, X-Ray Computed

2019
Mixed Connective Tissue Disease in a Patient With Castleman Disease and Hodgkin Lymphoma: Excellent Clinical Response to Rituximab.
    Actas dermo-sifiliograficas, 2015, Volume: 106, Issue:10

    Topics: Adrenal Cortex Hormones; Antimalarials; Antineoplastic Combined Chemotherapy Protocols; Castleman Disease; Drug Therapy, Combination; Hodgkin Disease; Humans; Male; Methylprednisolone; Middle Aged; Mixed Connective Tissue Disease; Raynaud Disease; Remission Induction; Rituximab

2015
Persistently elevated inflammatory markers and marked proteinuria due to Castleman disease.
    Polskie Archiwum Medycyny Wewnetrznej, 2015, Volume: 125, Issue:12

    Topics: Adult; Amyloidosis; Anti-Inflammatory Agents; C-Reactive Protein; Castleman Disease; Female; Humans; Kidney Diseases; Methylprednisolone; Proteinuria; Young Adult

2015
[Case of mesangial proliferative glomerulonephritis complicated with multicentric Castleman's disease].
    Nihon Jinzo Gakkai shi, 2011, Volume: 53, Issue:2

    Topics: Castleman Disease; Glomerulonephritis, IGA; Humans; Interleukin-6; Male; Methylprednisolone; Middle Aged; Prednisolone; Pulse Therapy, Drug; Treatment Outcome

2011
Successful treatment of a mesangial proliferative glomerulonephritis with interstitial nephritis associated with Castleman's disease by an anti-interleukin-6 receptor antibody (tocilizumab).
    Internal medicine (Tokyo, Japan), 2012, Volume: 51, Issue:11

    Topics: Antibodies, Monoclonal, Humanized; Castleman Disease; Glomerulonephritis, Membranoproliferative; Humans; Interleukin-6; Male; Methylprednisolone; Middle Aged; Nephritis, Interstitial; Receptors, Interleukin-6; Treatment Outcome

2012
Sometimes double negative is positive.
    Arthritis care & research, 2013, Volume: 65, Issue:1

    Topics: Abdominal Pain; Adrenal Cortex Hormones; Aged; Anti-Inflammatory Agents; Antibodies, Antinuclear; Autoimmune Lymphoproliferative Syndrome; Castleman Disease; Diagnosis, Differential; Humans; Hypoxia; Lymphatic Diseases; Male; Methylprednisolone; Neoplasms; Prednisolone; Rheumatoid Factor; T-Lymphocytes

2013
A case of multicentric Castleman's disease associated with renal amyloidosis and pure red cell aplasia.
    American journal of nephrology, 1998, Volume: 18, Issue:3

    Topics: Amyloidosis; Biopsy; Castleman Disease; Cyclophosphamide; Glucocorticoids; Humans; Kidney Diseases; Kidney Glomerulus; Lymph Nodes; Male; Methylprednisolone; Middle Aged; Plasma Exchange; Red-Cell Aplasia, Pure

1998
chemdatabank.com